Get Plus

Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

GlobesEconomy

Elron Acquisition Offer Presented at 100% Premium, Deal Deadline This Week

Translated & summarized from Globes by baba

Business

Hebrew · 1 newsroom

Elron's controlling shareholders, Ariel EL, have received an offer to sell their 58% stake for 6 shekels per share, a significant premium, with a deadline of November 19th. The deal would allow Ariel EL to repay a substantial debt to Phoenix Investments and potentially profit from its initial investment. The transaction is being led by Micha Laykin Avni, who is currently facing calls for a police investigation over controversial remarks. The deal also occurs amid internal disputes within Ariel LM, the parent entity of Ariel EL.

The story in 6 lines · by baba

  • Elron's controlling shareholders received an offer to sell their 58% stake at a 100% premium.
  • The offer is valid until Thursday, November 19th, with the stock currently frozen.
  • The deal would enable Ariel EL to repay a 90 million shekel debt to Phoenix Investments.
  • The acquiring company is Bluegate Capital, funded by the New York-based Melnik family.
  • Micha Laykin Avni, leading the deal's financial aspects, faces calls for a police investigation.
  • The transaction occurs amidst a dispute among partners at Ariel LM, including allegations of threats.

Elron announced that its controlling shareholders, Ariel EL, have received an offer to purchase their entire stake (58%) for 6 shekels per share, more than double the current market price. The offer is valid until Thursday, November 19th. The company's stock is currently frozen, with its market value at 155 million shekels.

The proposed transaction would allow Ariel EL to repay a 90 million shekel debt owed to Phoenix Investments, which was taken out to acquire control of Elron in July 2024. This loan had become a concern for Elron as Ariel EL failed to meet its terms following a drop in Elron's stock price. Phoenix had considered seizing Elron shares held as collateral and selling them to another buyer. Ariel EL has since repaid part of the loan, estimated at 20 million shekels, but the issue remained unresolved for Phoenix.

Under the new offer, Ariel EL would still relinquish its stake in Elron, but through a sale rather than a forced liquidation. The expected proceeds of approximately 180 million shekels would allow Ariel EL to repay Phoenix and still realize a profit of tens of millions of shekels on its initial investment of about 196 million shekels. Elron has distributed dividends during Ariel EL's ownership, with about 55 million shekels going to the controlling shareholder.

The acquiring company is Bluegate Capital, funded by the New York-based Melnik family, who have prior connections to Evan Renob, a partner at Ariel EL. The deal's financial aspects are being led by Micha Laykin Avni, CEO of non-bank credit company Peninsula and a former partner at VC fund JVP. He is not expected to hold a management role but will oversee operations for the controlling shareholder if the deal is approved.

Micha Laykin Avni recently drew controversy after claiming on Channel 14 that Arab doctors and nurses in Israeli hospitals poison Jewish patients. The State Attorney General, Gali Baharav-Miara, was asked by the State Doctors Union to order a police investigation into these remarks.

The deal is also occurring amidst a dispute among partners at Ariel LM: Evan Renob and Arik Ben Tov on one side, and partner Lisia Bachar-Manoh on the other. The partners disagreed on how to resolve the loan issue with Phoenix. Bachar-Manoh alleged receiving threats, and about a month ago, Renob and Ben Tov appointed new directors who ousted her as chairwoman, though she remains a director. Bachar-Manoh filed a complaint, deeming her removal unlawful.

Elron previously focused on medical devices and software, with past successes in companies like Given Imaging and Cartiheal. Under Bachar-Manoh's leadership as chairwoman, the company shifted focus to defense tech and cyber, divesting six holdings and making 20 new investments totaling $12 million. During this period, Elron distributed approximately $30 million in dividends, with over half going to the controlling shareholder. According to recent company reports, Elron has about $53 million in cash, indicating financial stability despite the controlling shareholder's challenges affecting the stock price.

GlobesOther · Rishon LeZion

Sign in to baba News

Sign in to follow newsrooms, topics and people.

or use an email code

EconomyTopic

Sign in to baba News

Sign in to follow newsrooms, topics and people.

or use an email code

Mentioned

Open the Wire